Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Management of Insomnia01:19

Management of Insomnia

543
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
543
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

519
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
519
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

1.4K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.4K
Insomnia01:27

Insomnia

413
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
413
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

1.2K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.2K
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

789
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
789

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Association between nonrestorative sleep and increased healthcare costs: a 6-year cohort study.

Sleep and biological rhythms·2026
Same author

Both underestimation and overestimation of sleep duration predict mortality in older men with sleep disturbances.

Scientific reports·2026
Same author

Combination of dysfunctional beliefs about sleep and excessive daytime sleepiness as a psychobehavioral characteristic of comorbid insomnia and sleep apnea.

Scientific reports·2026
Same author

The relationship between nonrestorative sleep and persistent post-acute sequelae of COVID-19: a longitudinal study of recovery trajectories.

Sleep and biological rhythms·2026
Same author

Effects of lemborexant on sleep quality and its association with morning alertness: Post hoc analysis of two phase 3 trials.

Sleep medicine: X·2026
Same author

Longitudinal association of nonrestorative sleep with subjective health and work performance: a cohort study in the Japanese construction industry.

Industrial health·2026

相关实验视频

Updated: Jan 18, 2026

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

3.0K

[治疗失眠的治疗应用]

Tomohiro Utsumi1, Kenichi Kuriyama

  • 1Department of Sleep-Wake Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry.

Brain and nerve = Shinkei kenkyu no shinpo
|September 11, 2025
PubMed
概括

数字疗法,包括失眠的数字认知行为疗法 (d-CBTI),显示出治疗睡眠障碍的前景. 这篇论文回顾了d-CBTI.

科学领域:

  • 数字健康创新数字健康创新
  • 医疗信息学医学信息学
  • 睡眠的药物 睡眠的药物

背景情况:

  • 由于医疗技术的进步,数字疗法正在出现.
  • 面对面的认知行为治疗失眠 (CBT-I) 是有效的,但面临着采用挑战.
  • 数字化转型正在影响医疗保健提供模式.

研究的目的:

  • 评估传统CBT-I的有效性和局限性.
  • 将数字CBT-I (d-CBTI) 的有效性进行分类和评估.
  • 探索d-CBTI在临床环境中的实施及其在日本的潜力.

主要方法:

  • 面对面的CBT-I. 的文献审查.
  • 数字CBT-I分类和证据的分析.
  • 审查d-CBTI实施策略和案例研究.
  • 讨论d-CBTI在日本的适用性和未来前景.

主要成果:

  • 面对面的CBT-I已经建立了有效性,但扩展性有限.
  • 数字CBT-I提供各种格式,已证明对失眠的有效性.
  • 实施挑战包括监管,技术和用户接受因素.

更多相关视频

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

1.6K
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

1.4K

相关实验视频

Last Updated: Jan 18, 2026

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

3.0K
Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

1.6K
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

1.4K
  • 在日本,d-CBTI为更广泛的失眠治疗提供了巨大潜力.
  • 结论:

    • 数字CBT-I是一种可行的,不断发展的治疗失眠的选择.
    • 解决实施障碍对于成功采用d-CBTI至关重要.
    • 在日本和全球范围内,d-CBTI对改善失眠护理具有相当大的前景.
    • 需要进一步的研究和政策制定,以支持d-CBTI的整合.